Nanotechnology and Cell Therapies for Ocular Diseases
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 31 March 2026 | Viewed by 71
Special Issue Editors
2. Faculty of Medical and Health Sciences, The University of Auckland, Auckland CBD, Auckland 1010, New Zealand
Interests: ophthalmic drugs and delivery systems; veterinary pharmaceuticals
Special Issues, Collections and Topics in MDPI journals
Interests: nanotechnology; stem cells; age-related macular degeneration; cataract; retinal detachment; antioxidants; drug delivery systems
Special Issue Information
Dear Colleagues,
We are pleased to announce a new Special Issue of Pharmaceutics, entitled “Nanotechnology and Cell Therapies for Ocular Diseases”, which is dedicated to showcasing recent advancements, innovative research, and emerging directions in this rapidly evolving field.
The human eye is a remarkably complex structure and a fertile ground for the development of cutting-edge therapeutic approaches, particularly within regenerative medicine. Recent research has increasingly focused on nanotechnology and cell-based therapies for a wide spectrum of ocular diseases. From corneal to retinal reconstruction, nanostructured matrices and nanomedicine-based drug delivery systems hold great promise in addressing some of the most prevalent vision-threatening conditions worldwide, including cataracts, age-related macular degeneration, diabetic retinopathy, and glaucoma.
Stem cell therapy is another area of intense investigation that encompasses a range of transplantation methods and cultivation techniques. While clinical success has already been achieved with stem cell-based treatments for corneal ulcers caused by limbal stem cell deficiency, applications for retinal repair remain under active study.
This Special Issue warmly welcomes contributions from across multiple disciplines—including pharmacology, ophthalmology, bioengineering, and related fields—with the strong conviction that collaborative efforts will accelerate progress in regenerative medicine and help bridge existing knowledge gaps.
Prof. Dr. Raid Alany
Dr. Ovidiu Samoilă
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanotechnology
- limbal stem cells
- cell cultivation techniques
- eye barriers
- drug delivery systems
- retinal degenerations
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
